MedPath

Quality Control of CE-Certified Phonak Hearing Aids - 2018_42

Not Applicable
Completed
Conditions
Sensorineural Hearing Loss
Hearing Loss
Interventions
Device: Audéo M90-T
Registration Number
NCT03938753
Lead Sponsor
Sonova AG
Brief Summary

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Detailed Description

In this study one CE-labeled Phonak Receiver-in-the-canal (RIC) devices is investigated. The experimental device will be investigated regarding Sound Quality perception ot the T-Coil program. A secondary objective of this study is the investigation of the Overall system stability in daily life situations. The experimental device contains direct connectivity functionality and a T-Coil. The combination of a wireless chip for Bluetooth streaming and a T-Coil in one housing can cause audible artifacts on the T-Coil, which shall be investigated within this study. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Adult hearing impaired persons (minimum age: 18 years, moderate to severe Hearing loss)
  • Good written and spoken (Swiss) German language skills
  • Healthy outer ear
  • Ability to fill in a questionnaire (p/eCRF) conscientiously
  • Willingness to wear Receiver in the canal hearing aids
  • Informed Consent as documented by signature
  • Owning a compatible smartphone
Exclusion Criteria
  • Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
  • Limited mobility and not in the position to attend weekly appointments in Stäfa (Switzerland)
  • Limited ability to describe listening impressions/experiences and the use of the hearing aid
  • Inability to produce a reliable hearing test result
  • Known psychological problems
  • Central hearing disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Phonak Audéo M90-TAudéo M90-TThe Phonak Audéo M90-T is a Receiver-in-the-canal Hearing aid with direct connectivity functionality and a T-Coil from Phonak which will be fitted to the participants individual Hearing loss.
Primary Outcome Measures
NameTimeMethod
Subjective perception of the T-Coil Sound Quality4 weeks

The primary objective of this study is to measure that the overall sound Quality of the T-Coil program \[subjective satisfaction rating on a scale from 0%-100% in 1% steps\] of the investigational device is rated as at least as 60% or better \[60% is the border between 'ok' and 'satisfied'\] after a test period with daily life situations.

Secondary Outcome Measures
NameTimeMethod
Program switch-back workflow into T-Coil program4 weeks

The number of incorrect switch-back occurences will be measured under laboratory conditions. A switch-back workflow is defined as the correct (re)activation of the T-Coil program, after an automatic program change into a streaming program. Due to an incoming phone call or due a start of audio streaming via Bluetooth, the investigational device will automatically switch into a streaming program. As soon as the Bluetooth stream stops, the investigation device must automatically toggle back into the T-Coil program (switch-back workflow).

Trial Locations

Locations (1)

Sonova AG

🇨🇭

Stäfa, Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath